Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.

Antiviral therapy - 1 Jan 2016

Ndahimana Jean d'Amour, Riedel David J, Muhayimpundu Ribakare, Nsanzimana Sabin, Niyibizi Gad, Mutaganzwa Emmanuel, Mulindabigwi Augustin, Baribwira Cyprien, Kiromera Athanase, Jagodzinski Linda L, Peel Sheila A, Redfield Robert R

Abstract excerpt

BACKGROUND: Studies of patients failing second-line antiretroviral therapy (ART) in resource-limited settings (RLS) are few. Evidence suggests most patients who appear to be virologically failing do so not due to drug resistance but to poor adherence, which, if properly addressed, could allow continued use of less expensive first- and second-line regimens. Drug resistant mutations (DRMs) were characterized among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Medication Adherence

Share to Mutation

Share to Rwanda

Source

Identifiers

PMID: 26562173
DOI: 10.3851/IMP3005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.PMID 26562173Read ↗

Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.Semantic proximity Read ↗

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.Semantic proximity Read ↗

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsSemantic proximity Read ↗

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesSemantic proximity Read ↗

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.Semantic proximity Read ↗

Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.Semantic proximity Read ↗

Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.Semantic proximity Read ↗

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya.Semantic proximity Read ↗

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read ↗

Prevalence and factors associated with drug resistance mutations among HIV - 1 patients failing to achieve virological suppression on second line treatment in Tanzania.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.